Clicky

Organon & Co(7XP)

Description: Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, a daily pill used to prevent pregnancy; Marvelon, progestin and estrogen used as daily pills to prevent pregnancy; Follistim AQ, used to promote the development of multiple ovarian follicles in assisted reproduction technology procedures; Elonva, an ovarian follicle stimulant; Ganirelix Acetate Injection, an injectable antagonist; and Jada, for abnormal postpartum uterine bleeding or hemorrhage. The company's biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; and two oncology products, including Ontruzant and Aybintio. It offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Atozet, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for treatments of control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. The company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. It sells its products to drug wholesalers and retailers, hospitals, pharmacies, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. The company was incorporated in 2020 and is headquartered in Jersey City, New Jersey.


Keywords: Pain Hypertension Pain Management Asthma Health Solutions Treatment Of Hypertension Oncology Products Contraception Respiratory Products Dermatology Products Hormonal Contraception Schering Plough Ganirelix Montelukast Seasonal Allergic Rhinitis Simvastatin Statins Diprosone Ganirelix Acetate Immunology Products Non Opioid Pain Management Products Vytorin

Home Page: www.organon.com

30 Hudson Street
Jersey City, NJ 07302
United States
Phone: 551 430 6900


Officers

Name Title
Mr. Kevin Ali CEO & Director
Mr. Matthew M. Walsh C.F.A. Executive VP & CFO
Mr. Kirke Weaver Executive VP, General Counsel & Corporate Secretary
Ms. Susanne Gabriele Fiedler Executive VP & Chief Commercial Officer
Mr. Joseph T. Morrissey Jr. Executive VP and Head of Manufacturing & Supply
Ms. Rachel A. Stahler Executive VP & Chief Information Officer
Ms. Jennifer Halchak Head of Investor Relations
Ms. Susan O'Neal Chief Ethics & Compliance Officer
Ms. Rebecca Lowell Edwards Chief Communications Officer
Mr. Daniel Karp Executive Vice President of Corporate Development

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 5.0201
Trailing PE: 2.9937
Price-to-Book MRQ: 7.8964
Price-to-Sales TTM: 0.5948
IPO Date:
Fiscal Year End: December
Full Time Employees: 10000
Back to stocks